GlassScriptPhysician profile
Angela Negron
NPI 1679091425
$112,431.83
in general payments reported to CMS, 2019-2025
8 companies · $21K in 2025
The $21K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $10K · 2022: $44K · 2023: $23K · 2024: $14K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $53K · Food and Beverage: $3,077 · Travel and Lodging: $2,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $52,745.00 |
| Food and Beverage | $3,076.65 |
| Travel and Lodging | $2,183.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $57,723.99 | 2023-2025 | |
| Allergan, INC. | $54,058.57 | 2021-2022 | |
| Galderma Laboratories, L.P. | $379.08 | 2021-2025 | Dysport |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.66 | 2022 | |
| Davol INC. | $68.60 | 2023 | Phasix Mesh |
| Abbott Laboratories | $29.28 | 2022 | |
| Revance Therapeutics, INC. | $27.28 | 2025 | Daxxify |
| Vertex Pharmaceuticals Incorporated | $25.37 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Negron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.